|
- 2017
Multiple doses of icatibant used during pregnancyKeywords: Hereditary angioedema, pregnancy, icatibant, adverse events, gestation, C1-inhibitor, bradykinin, decidua Abstract: Hereditary angioedema (HAE) is a life-long disease that often manifests by puberty. Treatment of attacks is essential to improve quality of life and to decrease morbidity and mortality. During pregnancy, treatment is limited because multiple treatment options, including icatibant, are not approved for use during pregnancy
|